---
figid: PMC10892755__pharmaceutics-16-00214-g001
pmcid: PMC10892755
image_filename: PMC10892755__pharmaceutics-16-00214-g001.jpg
figure_link: /pmc/articles/PMC10892755/figure/F1/
number: Figure 1
figure_title: Cholesterol and isoprenoid synthesis pathway illustrating how statins
  inhibit the enzyme 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase.
caption: Cholesterol and isoprenoid synthesis pathway illustrating how statins inhibit
  the enzyme 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase. Created with
  BioRender.com. Accessed on 4 October 2023
article_title: Potential Benefits and Risks Associated with the Use of Statins
citation: Nisha Khatiwada, et al. Pharmaceutics. 2024 Feb;16(2).
year: '2024'
pub_date: 2024-2-
epub_date: 2024-2-01
doi: 10.3390/pharmaceutics16020214
journal_title: Pharmaceutics
journa_nlm_ta: Pharmaceutics
publisher_name: MDPI
keywords:
- statin
- pleiotropic effects
- statin-associated symptoms
---
